pinched this from Hottod on the POH threads. qrx get a mention so its worth a listen if you have a few minutes spare. http://www.openbriefing.com/OB/AusBiotech-Ltd/2013/6/3/Asia-Biotech-Invest/1101.aspx
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status